ERCC1 plays a key role in the DNA repair pathway, and has been demonstrated that lung and gastric cancer patients with lower mRNA expression levels of ERCC1 could benefit from platinum-based chemotherapy[21]–[23]. This evidence concerns the gene ERCC1 and gastric cancer.